Modulation of choline kinase activity in human cancer cells observed by dynamic 31P NMR
- PMID: 19156696
- DOI: 10.1002/nbm.1361
Modulation of choline kinase activity in human cancer cells observed by dynamic 31P NMR
Abstract
Choline metabolites are widely studied in cancer research as biomarkers of malignancy and as indicators of therapeutic response. However, endogenous phosphocholine levels are determined by a number of processes that confound the interpretation of these measurements, including membrane transport rates and a series of enzyme catalysed reactions in the Kennedy pathway. Employing a dynamic (31)P NMR assay that is specific to choline kinase (ChoK) we have measured the rates of this enzyme reaction in cell lysates of MDA-MB-231 breast, PC-3 prostate and HeLa cervical cancer cells and in solutions of purified human ChoK. The rates are sensitive to inhibition by hemicholinium-3 (HC-3), a competitive ChoK inhibitor, and to N-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulphonamide (H-89), an agent commercialized as a specific cyclic-AMP-dependent protein kinase A (PKA) inhibitor.
Similar articles
-
N-[2-bromocinnamyl(amino)ethyl]-5-isoquinolinesulphonamide (H-89) inhibits incorporation of choline into phosphatidylcholine via inhibition of choline kinase and has no effect on the phosphorylation of CTP:phosphocholine cytidylyltransferase.Biochem J. 1994 Jan 1;297 ( Pt 1)(Pt 1):241-7. doi: 10.1042/bj2970241. Biochem J. 1994. PMID: 8280105 Free PMC article.
-
Noninvasive magnetic resonance spectroscopic pharmacodynamic markers of the choline kinase inhibitor MN58b in human carcinoma models.Cancer Res. 2006 Jan 1;66(1):427-34. doi: 10.1158/0008-5472.CAN-05-1338. Cancer Res. 2006. PMID: 16397258
-
The phosphoinositide 3-kinase inhibitor PI-103 downregulates choline kinase alpha leading to phosphocholine and total choline decrease detected by magnetic resonance spectroscopy.Cancer Res. 2010 Jul 1;70(13):5507-17. doi: 10.1158/0008-5472.CAN-09-4476. Epub 2010 Jun 15. Cancer Res. 2010. PMID: 20551061 Free PMC article.
-
Choline kinase: an important target for cancer.Curr Med Chem. 2006;13(10):1169-86. doi: 10.2174/092986706776360923. Curr Med Chem. 2006. PMID: 16719778 Review.
-
Choline kinase alpha-Putting the ChoK-hold on tumor metabolism.Prog Lipid Res. 2016 Jul;63:28-40. doi: 10.1016/j.plipres.2016.03.005. Epub 2016 Apr 9. Prog Lipid Res. 2016. PMID: 27073147 Free PMC article. Review.
Cited by
-
Multimodal mass spectrometric imaging of small molecules reveals distinct spatio-molecular signatures in differentially metastatic breast tumor models.Cancer Res. 2010 Nov 15;70(22):9012-21. doi: 10.1158/0008-5472.CAN-10-0360. Epub 2010 Nov 2. Cancer Res. 2010. PMID: 21045154 Free PMC article.
-
A non-catalytic role of choline kinase alpha is important in promoting cancer cell survival.Oncogenesis. 2013;2(3):e38. doi: 10.1038/oncsis.2013.2. Oncogenesis. 2013. PMID: 25522435 Free PMC article.
-
Choline induces opposite changes in pyramidal neuron excitability and synaptic transmission through a nicotinic receptor-independent process in hippocampal slices.Pflugers Arch. 2017 Jun;469(5-6):779-795. doi: 10.1007/s00424-017-1939-5. Epub 2017 Feb 8. Pflugers Arch. 2017. PMID: 28176016
-
HDAC inhibition induces increased choline uptake and elevated phosphocholine levels in MCF7 breast cancer cells.PLoS One. 2013 Apr 23;8(4):e62610. doi: 10.1371/journal.pone.0062610. Print 2013. PLoS One. 2013. PMID: 23626839 Free PMC article.
-
A decade in prostate cancer: from NMR to metabolomics.Nat Rev Urol. 2011 May 17;8(6):301-11. doi: 10.1038/nrurol.2011.53. Nat Rev Urol. 2011. PMID: 21587223 Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous